Sunlenca® (Lenacapavir): A first-in-class, long-acting HIV-1 capsid inhibitor for treating highly multidrug-resistant HIV-1 infection.
作者信息
Ma Chunhua, Chang Junbiao, Yu Bin
机构信息
State Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, NMPA Key Laboratory for Research and Evaluation of Innovative Drug, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, 453007, China.
College of Chemistry, Pingyuan Laboratory, State Key Laboratory of Antiviral Drugs, Zhengzhou University, Zhengzhou 450001, China.
出版信息
Acta Pharm Sin B. 2024 Dec;14(12):5512-5514. doi: 10.1016/j.apsb.2024.08.009. Epub 2024 Aug 14.
Abstract
摘要
Zotero 插件